Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 228

The DOI matches its Crossref record.

Sex and gender differences in symptoms of myocardial ischaemia

Regitz-Zagrosek, V. · 2011 · European Heart Journal

Abstract

This editorial refers to ‘Gender differences in symptoms of myocardial ischaemia'†, by M.H. Mackay et al., on page 3107 Women with acute coronary syndromes (ACS) or myocardial infarction (MI) still undergo treatment significantly later than men. The reasons for this are unclear, but so-called ‘atypical symptoms’ in women have been under suspicion.1 Women are assumed to complain of anginal symptoms that differ from the classical picture of those of men, making diagnosis more difficult and delaying effective therapy. This phenomenon is of great relevance for healthcare in women and therefore has been investigated in numerous studies.2 It has been discussed whether sex or gender is the crucial factor for different presentation—whether differences exist between women and men in the biological mechanisms of pain, i.e. sex, or whether socio-cultural mechanisms, such as lack of awareness of risk or reporting behaviour, mainly contribute to the differences, i.e. gender. Do women have a different form of angina from men, do they interpret pain differently, or do they report it differently? A significant number of studies analysing sex and gender differences in the presentation of MI and angina pectoris agree that women differ from men in their reported symptoms, even though the differences may be small. Most of these studies necessarily had a retrospective design, inquiring of patients after the events concerning the related symptoms. Only studies that focus on a first MI avoid the recall effect—that patients learn from doctors and friends during a first MI which symptoms are to be expected. In such studies, relatively persistent findings are the greater number of symptoms in women and the greater frequency of nausea and pain in the throat or jaws, among others.3 The large WISE study investigated a broader spectrum of women,4 covering all women presenting with chest pain in the participating hospitals. The investigators found that chest pain had a lower predictive value for obstructive coronary artery disease (CAD) in women than in men, particularly in younger women, and concluded that this was due to the relatively large prevalence of non-obstructive CAD in the latter cohort. From 10% to 30% of women presenting with ACS, non-ST elevation myocardial infarction (NSTEMI), or STEMI do not exhibit major coronary stenoses at angiography, as compared with 3–15% of men.5 Women with non-obstructive CAD frequently present with atypical angina; the pain may be more intense and it may persist for ≥30 min.6 The WISE investigators suggested specific algorithms to detect myocardial ischaemia objectively in these women in addition to coronary angiography, which only detects large vessel obstruction. The WISE investigators suggested techniques to measure myocardial perfusion disturbances that may be due to defects in coronary vasodilatation or to disturbances of the microcirculation, and that occur in the absence of major stenoses of the epicardial arteries, by magnetic resonance imaging (MRI), scintigraphic techniques, or Doppler flow measurements in the coronary arteries after the administration of vasodilating agents.7 They systematically followed the women with chest pain and evidence of myocardial ischaemia but without obstructive lesions. The follow-up of the affected women was characterized by an increased number of major cardiac events (MACEs), high rates of rehospitalization, and high treatment costs.8 Thus, non-obstructive CAD may be associated with myocardial ischaemia and has consequences for the clinical outcomes, so that future studies of myocardial ischaemia in women will need to include these cohorts, too. Pain generation in the heart is a complex process (Figure 1). It starts with the stimulation of afferent nerve endings in the heart. Nerve growth factor (NGF) is one of the substances involved in cardiac pain sensation.9 NGF leads to vallinoid receptor activation and stimulation of afferent nerves in the heart. Regarding this first step, it has not yet been established whether vallinoid receptors and NGF are differently expressed in female and male hearts. Both are reduced in diabetic hearts, and this may contribute to the occurrence of silent ischaemia in patients with diabetes. Their manipulation modulates pain sensation in an ischaemic transgenic mouse model. In addition, activation of the RAGE (receptor for advanced glycation end-products)–NF-κB (nuclear factor-κB) axis prevents pain sensation in diabetic hearts.10 Neuropathy is particularly frequent in diabetic patients, the elderly, and smokers, and may be mediated by RAGE and the NF-κB pathway. Diabetic neuropathy is also related to reduced synthesis of NGF, and depletion of calcitonin gene-related peptide (a marker for nociceptory nerves)-containing neurons. In addition to female gender, diabetes and old age are associated with atypical presentation of myocardial ischaemia, and their effects as modulating factors should be discussed. Anatomical and functio

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr272

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 15

  1. Regitz-Zagrosek, 2006, Nature reviews. Drug discovery, 5, 425, 10.1038/nrd2032 · DOI · Paper page
  2. Arslanian-Engoren, 2010, Heart & lung : the journal of critical care, 39, 386, 10.1016/j.hrtlng.2009.10.013 · DOI
  3. Kirchberger, 2011, The American journal of cardiology, 107, 1585, 10.1016/j.amjcard.2011.01.040 · DOI
  4. Shaw, 2009, Journal of the American College of Cardiology, 54, 1561, 10.1016/j.jacc.2009.04.098 · DOI · Paper page
  5. Bugiardini, 2005, JAMA, 293, 477, 10.1001/jama.293.4.477 · DOI · Paper page
  6. 2004, Circulation, 109, 2518, 10.1161/01.CIR.0000128208.22378.E3 · DOI · Paper page
  7. Pohost, 1990, New England Journal of Medicine, 323, 190, 10.1056/NEJM199007193230309 · DOI
  8. 2004, Circulation, 109, 2993, 10.1161/01.CIR.0000130642.79868.B2 · DOI · Paper page
  9. 2006, Circulation, 114, 2351, 10.1161/CIRCULATIONAHA.106.627588 · DOI
  10. Bierhaus, 2004, Journal of Clinical Investigation, 114, 1741, 10.1172/JCI200418058 · DOI
  11. Dodge, 1988, Circulation, 78, 1167, 10.1161/01.CIR.78.5.1167 · DOI · Paper page
  12. Rosen, 1996, Annals of Internal Medicine, 124, 939, 10.1001/archinte.156.9.939 · DOI
  13. Akhan, 2002, Gynecologic and obstetric investigation, 54, 196, 10.1159/000068382 · doi:10.1159/000068382
  14. Robinson, 2001, The journal of pain : official journal of the American Pain Society, 2, 251, 10.1054/jpai.2001.24551 · DOI · Paper page
  15. 2011, European Heart Journal, 32, 3107, 10.1093/eurheartj/ehr358 · DOI · Paper page

Cited by

See all 228

Metadata

Authors
Regitz-Zagrosek, V.
Venue
European Heart Journal
Published
2011-09-14
Volume
32
Issue
24
Pages
3064-3066
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2155055978
Cited by
228
References
0
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex and gender differences in symptoms of myocardial ischaemia. https://app.cochat.ai/papers/10.1093/eurheartj/ehr272
The paper
Regitz-Zagrosek, V. (2011). Sex and gender differences in symptoms of myocardial ischaemia. European Heart Journal. https://doi.org/10.1093/eurheartj/ehr272

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.